{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T22:22:46Z","timestamp":1783030966259,"version":"3.54.6"},"reference-count":69,"publisher":"MDPI AG","issue":"5","license":[{"start":{"date-parts":[[2022,4,24]],"date-time":"2022-04-24T00:00:00Z","timestamp":1650758400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pharmaceutics"],"abstract":"<jats:p>As drug delivery to the eye has evolved over the last decades, researchers have explored more effective treatments for ocular diseases. Despite this, delivering drugs to the cornea remains one of the most problematic issues in ophthalmology due to the poor permeability of the cornea and tear clearance mechanisms. In this study, four different types of polyaphron formulations are prepared with 10% poloxamer 188 (P188), 10% poly(2-ethyl-2-oxazoline), 1% polyquaternium 10, and 3% sodium carboxymethylcellulose solutions mixed with 1% Brij\u00ae L4 in a caprylic\/capric triglycerides solution. Their physicochemical characteristics, rheological properties, and stability are assessed. Additionally, a polyaphron with 3% polyquaternium 10 was prepared for the assessment of ex vivo corneal retention along with four other polyaphrons. The best retention on the ex vivo cornea was displayed by the 3% polyquaternium 10-based formulation. The 10% poloxamer 188 along with 1% polyquaternium 10-based polyaphrons appeared to be the most stable among the four prepared formulations. A toxicological evaluation of these formulations was performed using a slug mucosal irritation test and bovine corneal opacity and permeability assay, with all four polyaphrons proving good biocompatibility with ocular tissues. The developed drug delivery systems demonstrated an excellent potential for ocular drug delivery.<\/jats:p>","DOI":"10.3390\/pharmaceutics14050926","type":"journal-article","created":{"date-parts":[[2022,4,24]],"date-time":"2022-04-24T22:22:41Z","timestamp":1650838961000},"page":"926","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Polyaphron Formulations Stabilised with Different Water-Soluble Polymers for Ocular Drug Delivery"],"prefix":"10.3390","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4358-9981","authenticated-orcid":false,"given":"Roman V.","family":"Moiseev","sequence":"first","affiliation":[{"name":"Reading School of Pharmacy, University of Reading, Whiteknights, Reading RG6 6DX, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fraser","family":"Steele","sequence":"additional","affiliation":[{"name":"MC2 Therapeutics, 1A Guildford Business Park Rd., Guildford GU2 8XG, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7221-2630","authenticated-orcid":false,"given":"Vitaliy V.","family":"Khutoryanskiy","sequence":"additional","affiliation":[{"name":"Reading School of Pharmacy, University of Reading, Whiteknights, Reading RG6 6DX, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2022,4,24]]},"reference":[{"key":"ref_1","unstructured":"WHO (2022, January 17). Blindness and Vision Impairment. Available online: https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/blindness-and-visual-impairment."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/0169-409X(95)00107-I","article-title":"Prodrugs for improved ocular drug delivery","volume":"19","year":"1996","journal-title":"Adv. Drug Deliv. Rev."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/j.plipres.2004.09.001","article-title":"Oil-in-water lipid emulsions: Implications for parenteral and ocular delivering systems","volume":"43","author":"Tamilvanan","year":"2004","journal-title":"Prog. Lipid Res."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/0169-409X(95)00012-V","article-title":"Ocular drug delivery conventional ocular formulations","volume":"16","author":"Lang","year":"1995","journal-title":"Adv. Drug Deliv. Rev."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1089\/jop.2019.0135","article-title":"Novel ocular drug delivery systems: An update on microemulsions","volume":"36","author":"Siafaka","year":"2020","journal-title":"J. Ocul. Pharmacol. Ther."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1007\/s13346-016-0339-2","article-title":"A comprehensive insight on ocular pharmacokinetics","volume":"6","author":"Agrahari","year":"2016","journal-title":"Drug Deliv. Transl. Res."},{"key":"ref_7","first-page":"121","article-title":"Therapeutic challenges in ocular delivery of lipid based emulsion","volume":"5","author":"Tiwari","year":"2018","journal-title":"Egypt. J. Basic Appl. Sci."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/S0939-6411(96)00036-7","article-title":"Development and characterization of microemulsions for ocular application","volume":"43","author":"Keipert","year":"1997","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.colsurfb.2018.09.063","article-title":"Potentiality of microemulsion systems in treatment of ophthalmic disorders: Keratoconus and dry eye syndrome\u2013In vivo study","volume":"173","author":"Lidich","year":"2019","journal-title":"Colloids Surf. B Biointerfaces"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/j.jcis.2015.02.011","article-title":"Water-dilutable microemulsions for transepithelial ocular delivery of riboflavin phosphate","volume":"463","author":"Lidich","year":"2016","journal-title":"J. Colloid Interface Sci."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.ijpharm.2007.08.057","article-title":"Stable drug encapsulation in micelles and microemulsions","volume":"345","author":"Narang","year":"2007","journal-title":"Int. J. Pharm."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1081\/PDT-100102035","article-title":"Influence of emulsion droplet surface charge on indomethacin ocular tissue distribution","volume":"5","author":"Klang","year":"2000","journal-title":"Pharm. Dev. Technol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"886","DOI":"10.3109\/10717544.2014.920432","article-title":"Delivery of gatifloxacin using microemulsion as vehicle: Formulation, evaluation, transcorneal permeation and aqueous humor drug determination","volume":"23","author":"Kalam","year":"2016","journal-title":"Drug Deliv."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1089\/jop.2013.0114","article-title":"Novel ofloxacin-loaded microemulsion formulations for ocular delivery","volume":"30","author":"Ertan","year":"2014","journal-title":"J. Ocul. Pharmacol. Ther."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/S1350-9462(01)00017-9","article-title":"Microemulsions as ocular drug delivery systems: Recent developments and future challenges","volume":"21","author":"Vandamme","year":"2002","journal-title":"Prog. Retin. Eye Res."},{"key":"ref_16","unstructured":"Benita, S., and Elbaz, E. (1993). Oil-in-Water Emulsions of Positively Charged Particles. (Application No. 1993018852A9), WO Patent."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/S1773-2247(11)50010-3","article-title":"Emulsions and microemulsions for ocular drug delivery","volume":"21","author":"Peng","year":"2011","journal-title":"J. Drug Deliv. Sci. Technol."},{"key":"ref_18","unstructured":"Benita, S., and Muchtar, S. (1993). Ophthalmic Compositions. (Application No. 0521799A1), EP Patent."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/0021-9797(72)90356-6","article-title":"Biliquid foams\u2014A preliminary report","volume":"40","author":"Sebba","year":"1972","journal-title":"J. Colloid Interface Sci."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1007\/BF01521575","article-title":"The behaviour of minute oil droplets encapsulated in a water film","volume":"257","author":"Sebba","year":"1979","journal-title":"Colloid Polym. Sci."},{"key":"ref_21","unstructured":"Sebba, F. (1987). Foams and Biliquid Foams, Aphrons, Wiley."},{"key":"ref_22","unstructured":"Wheeler, D.A., and Steele, D.F. (2010). Pharmaceutical Composition. (Application No. 2010\/0260835 A1), U.S. Patent."},{"key":"ref_23","unstructured":"Wheeler, D.A., Steele, D.F., Georgiou, M., and Sindet-Pedersen, S. (2008). Topical Composition. (Application No. 2008\/0234239 A1), U.S. Patent."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/S0014-5793(98)00771-6","article-title":"Cytochrome P450 immobilisation as a route to bioremediation\/biocatalysis","volume":"431","author":"Lamb","year":"1998","journal-title":"FEBS Lett."},{"key":"ref_25","first-page":"339","article-title":"Extraction of erythromycin-A using colloidal liquid aphrons: I. Equilibrium partitioning","volume":"75","author":"Lye","year":"2000","journal-title":"J. Chem. Technol. Biotechnol. Int. Res. Process Environ. Clean Technol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/S0009-2509(00)00141-X","article-title":"Extraction of erythromycin-A using colloidal liquid aphrons: Part II. Mass transfer kinetics","volume":"56","author":"Lye","year":"2001","journal-title":"Chem. Eng. Sci."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.ejpb.2017.03.006","article-title":"Cyclosporine A delivery to the eye: A comprehensive review of academic and industrial efforts","volume":"117","author":"Lallemand","year":"2017","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/S0168-3659(01)00279-6","article-title":"Sustained ophthalmic delivery of ofloxacin from a pH triggered in situ gelling system","volume":"73","author":"Srividya","year":"2001","journal-title":"J. Control. Release"},{"key":"ref_29","unstructured":"Chang, A.Y., and Purt, B. (2021). Biochemistry, Tear Film. StatPearls [Internet], StatPearls Publishing."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/0039-6257(81)90145-4","article-title":"Clinical biochemistry of tears","volume":"26","year":"1981","journal-title":"Surv. Ophthalmol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.ijpharm.2012.02.047","article-title":"A flow system for the on-line quantitative measurement of the retention of dosage forms on biological surfaces using spectroscopy and image analysis","volume":"428","author":"Cave","year":"2012","journal-title":"Int. J. Pharm."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"6593","DOI":"10.1167\/iovs.10-5659","article-title":"The relationship between body and ambient temperature and corneal temperature","volume":"51","author":"Kessel","year":"2010","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1002\/mabi.201300313","article-title":"Hydrogen-Bonded Complexes and Blends of Poly (acrylic acid) and Methylcellulose: Nanoparticles and Mucoadhesive Films for Ocular Delivery of Riboflavin","volume":"14","author":"Khutoryanskaya","year":"2014","journal-title":"Macromol. Biosci."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ijpharm.2012.04.063","article-title":"Conjunctival and corneal tolerability assessment of ocular naltrexone niosomes and their ingredients on the hen\u2019s egg chorioallantoic membrane and excised bovine cornea models","volume":"432","author":"Abdelkader","year":"2012","journal-title":"Int. J. Pharm."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1093\/toxsci\/18.3.442","article-title":"Bovine corneal opacity and permeability test: An in vitro assay of ocular irritancy","volume":"18","author":"Gautheron","year":"1992","journal-title":"Toxicol. Sci."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1038\/s41433-021-01668-x","article-title":"Ocular benzalkonium chloride exposure: Problems and solutions","volume":"36","author":"Goldstein","year":"2021","journal-title":"Eye"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.eurpolymj.2019.04.016","article-title":"Chitosan\/poly (2-ethyl-2-oxazoline) films for ocular drug delivery: Formulation, miscibility, in vitro and in vivo studies","volume":"116","author":"Abilova","year":"2019","journal-title":"Eur. Polym. J."},{"key":"ref_38","doi-asserted-by":"crossref","unstructured":"Hwang, Y.-S., Chiang, P.-R., Hong, W.-H., Chiao, C.-C., Chu, I.-M., Hsiue, G.-H., and Shen, C.-R. (2013). Study in vivo intraocular biocompatibility of in situ gelation hydrogels: Poly (2-ethyl oxazoline)-block-poly (\u03b5-caprolactone)-block-poly (2-ethyl oxazoline) copolymer, matrigel and pluronic F127. PLoS ONE, 8.","DOI":"10.1371\/journal.pone.0067495"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1007\/s10856-014-5358-2","article-title":"Ocular biocompatibility of polyquaternium 10 gel: Functional and morphological results","volume":"26","author":"Alasino","year":"2015","journal-title":"J. Mater. Sci. Mater. Med."},{"key":"ref_40","doi-asserted-by":"crossref","unstructured":"(1988). 3 Final Report on the Safety Assessment of Polyquaternium-10. J. Am. Coll. Toxicol., 7, 335\u2013351.","DOI":"10.3109\/10915818809023135"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1038\/eye.2017.73","article-title":"Osmoprotectants, carboxymethylcellulose and hyaluronic acid multi-ingredient eye drop: A randomised controlled trial in moderate to severe dry eye","volume":"31","author":"Labetoulle","year":"2017","journal-title":"Eye"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1167\/iovs.06-0848","article-title":"Carboxymethylcellulose binds to human corneal epithelial cells and is a modulator of corneal epithelial wound healing","volume":"48","author":"Garrett","year":"2007","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"ref_43","unstructured":"Taylor, K.M., and Aulton, M.E. (2017). Ocular Drug Delivery. Aulton\u2019s Pharmaceutics E-Book: The Design and Manufacture of Medicines, Elsevier Health Sciences. [5th ed.]."},{"key":"ref_44","doi-asserted-by":"crossref","unstructured":"Lu, G., and Gao, P. (2010). CHAPTER 3\u2014Emulsions and Microemulsions for Topical and Transdermal Drug Delivery A2\u2014Kulkarni, Vitthal S. Handbook of Non-Invasive Drug Delivery Systems, William Andrew Publishing.","DOI":"10.1016\/B978-0-8155-2025-2.10003-4"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/S0927-7757(96)03931-3","article-title":"Structure and stability of colloidal liquid aphrons","volume":"131","author":"Lye","year":"1998","journal-title":"Colloids Surf. A Physicochem. Eng. Asp."},{"key":"ref_46","doi-asserted-by":"crossref","unstructured":"Sheng, J.J. (2010). Alkaline-Surfactant-Polymer Flooding. Modern Chemical Enhanced Oil Recovery: Theory and Practice, Elsevier Science.","DOI":"10.1016\/B978-1-85617-745-0.00013-9"},{"key":"ref_47","unstructured":"Macosko, C.W. (1994). Rheology principles. Measurements and Applications, Wiley."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.1021\/la052207h","article-title":"Rheology of high internal phase emulsions","volume":"22","author":"Welch","year":"2006","journal-title":"Langmuir"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1016\/j.drudis.2019.05.036","article-title":"Poloxamer-based in situ gelling thermoresponsive systems for ocular drug delivery applications","volume":"24","author":"Soliman","year":"2019","journal-title":"Drug Discov. Today"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1001\/archopht.1945.00890170054004","article-title":"Use of methyl cellulose in ophthalmology","volume":"33","author":"SWAN","year":"1945","journal-title":"Arch. Ophthalmol."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1016\/j.addr.2005.07.005","article-title":"The use of mucoadhesive polymers in ocular drug delivery","volume":"57","author":"Ludwig","year":"2005","journal-title":"Adv. Drug Deliv. Rev."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1089\/jop.1986.2.67","article-title":"Topical ocular drug delivery: Recent developments and future challenges","volume":"2","author":"Lee","year":"1986","journal-title":"J. Ocul. Pharmacol. Ther."},{"key":"ref_53","first-page":"3152","article-title":"Clinical performance of a new mid-viscosity artificial tear for dry eye treatment","volume":"43","author":"Prather","year":"2002","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"ref_54","doi-asserted-by":"crossref","unstructured":"Paugh, J.R., Chatelier, R.C., and Huff, J.W. (1998). Ocular residence time of carboxymethylcellulose solutions. Lacrimal Gland, Tear Film, and Dry Eye Syndromes 2, Springer.","DOI":"10.1007\/978-1-4615-5359-5_107"},{"key":"ref_55","first-page":"377","article-title":"Methods for the study of irritation and toxicity of substances applied topically to the skin and mucous membranes","volume":"82","author":"Draize","year":"1944","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"ref_56","first-page":"477","article-title":"Validation of alternative methods for toxicity testing","volume":"106","author":"Bruner","year":"1998","journal-title":"Environ. Health Perspect."},{"key":"ref_57","unstructured":"EMA (2022, January 27). Ethical Use of Animals in Medicine Testing. Available online: https:\/\/www.ema.europa.eu\/en\/human-regulatory\/research-development\/ethical-use-animals-medicine-testing."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/S0039-6257(01)00211-9","article-title":"The Draize eye test","volume":"45","author":"Wilhelmus","year":"2001","journal-title":"Surv. Ophthalmol."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.tiv.2009.05.019","article-title":"A proposed eye irritation testing strategy to reduce and replace in vivo studies using bottom\u2013up and top\u2013down approaches","volume":"24","author":"Scott","year":"2010","journal-title":"Toxicol. Vitr."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"1919","DOI":"10.1016\/j.tiv.2011.06.009","article-title":"The slug mucosal irritation (SMI) assay: Development of a screening tool for the evaluation of ocular discomfort caused by shampoos","volume":"25","author":"Lenoir","year":"2011","journal-title":"Toxicol. Vitr."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.tiv.2004.06.004","article-title":"Refinement of the Slug Mucosal Irritation test as an alternative screening test for eye irritation","volume":"19","author":"Adriaens","year":"2005","journal-title":"Toxicol. Vitr."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1016\/j.tiv.2013.02.018","article-title":"Improvement of the Bovine Corneal Opacity and Permeability (BCOP) assay as an in vitro alternative to the Draize rabbit eye irritation test","volume":"27","author":"Verstraelen","year":"2013","journal-title":"Toxicol. Vitr."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"191","DOI":"10.5487\/TR.2017.33.3.191","article-title":"Alternatives to in vivo Draize rabbit eye and skin irritation tests with a focus on 3D reconstructed human cornea-like epithelium and epidermis models","volume":"33","author":"Lee","year":"2017","journal-title":"Toxicol. Res."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1023\/A:1014801714590","article-title":"Gastropods as an evaluation tool for screening the irritating potency of absorption enhancers and drugs","volume":"16","author":"Adriaens","year":"1999","journal-title":"Pharm. Res."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1023\/A:1010928025753","article-title":"The mucosal toxicity of different benzalkonium chloride analogues evaluated with an alternative test using slugs","volume":"18","author":"Adriaens","year":"2001","journal-title":"Pharm. Res."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.ejpb.2019.08.007","article-title":"Maleimide-functionalised PLGA-PEG nanoparticles as mucoadhesive carriers for intravesical drug delivery","volume":"143","author":"Kaldybekov","year":"2019","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1080\/10915810802244595","article-title":"Safety assessment of poloxamers 101, 105, 108, 122, 123, 124, 181, 182, 183, 184, 185, 188, 212, 215, 217, 231, 234, 235, 237, 238, 282, 284, 288, 331, 333, 334, 335, 338, 401, 402, 403, and 407, poloxamer 105 benzoate, and poloxamer 182 dibenzoate as used in cosmetics","volume":"27","author":"McLain","year":"2008","journal-title":"Int. J. Toxicol."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1177\/026119291103900119","article-title":"The bovine corneal opacity and permeability test in routine ocular irritation testing and its improvement within the limits of OECD test guideline 437","volume":"39","author":"Schrage","year":"2011","journal-title":"Altern. Lab. Anim."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"3528","DOI":"10.1021\/acs.molpharmaceut.7b00556","article-title":"Crown ethers: Novel permeability enhancers for ocular drug delivery?","volume":"14","author":"Morrison","year":"2017","journal-title":"Mol. Pharm."}],"container-title":["Pharmaceutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1999-4923\/14\/5\/926\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T22:59:41Z","timestamp":1760137181000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1999-4923\/14\/5\/926"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4,24]]},"references-count":69,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2022,5]]}},"alternative-id":["pharmaceutics14050926"],"URL":"https:\/\/doi.org\/10.3390\/pharmaceutics14050926","relation":{},"ISSN":["1999-4923"],"issn-type":[{"value":"1999-4923","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,4,24]]}}}